Loading...
Header Logo
Keywords
Last Name
Institution

Hooman Yari

TitleAsst,Grad Teaching/Grad Col
InstitutionUniversity of Oklahoma Health Sciences Center
DepartmentPharmacy Instructional Science
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Yari H, Nkepang G, Awasthi V. Surface Modification of Liposomes by a Lipopolymer Targeting Prostate Specific Membrane Antigen for Theranostic Delivery in Prostate Cancer. Materials (Basel). 2019 Mar 05; 12(5). PMID: 30841602.
      View in: PubMed
    2. Rao G, Nkepang G, Xu J, Yari H, Houson H, Teng C, Awasthi V. Ubiquitin Receptor RPN13 Mediates the Inhibitory Interaction of Diphenyldihaloketones CLEFMA and EF24 With the 26S Proteasome. Front Chem. 2018; 6:392. PMID: 30280096.
      View in: PubMed
    3. Rao G, Houson H, Nkepang G, Yari H, Teng C, Awasthi V. Induction of gut proteasome activity in hemorrhagic shock and its recovery by treatment with diphenyldihaloketones CLEFMA and EF24. Am J Physiol Gastrointest Liver Physiol. 2018 08 01; 315(2):G318-G327. PMID: 29746173.
      View in: PubMed
    4. Raghuvanshi D, Nkepang G, Hussain A, Yari H, Awasthi V. Stability study on an anti-cancer drug 4-(3,5-bis(2-chlorobenzylidene)-4-oxo-piperidine-1-yl)-4-oxo-2-butenoic acid (CLEFMA) using a stability-indicating HPLC method. J Pharm Anal. 2017 Feb; 7(1):1-9. PMID: 29404012.
      View in: PubMed
    Yari's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Same Department Expand Description